Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.

A research group led by Assistant Professor Megumi Aimoto and Professor Akira Takahara at the Faculty of Pharmaceutical Sciences, Toho University, revealed that pyrazole-3 (Pyr3), a selective ...

Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.

Despite being the most common form of cardiac arrhythmia, atrial fibrillation (AFib) is a condition that often goes undiagnosed and/or untreated. The condition, which often accompanies other health ...

Share on Pinterest New research suggests that there may be more than 10.5 million people in the United States living with atrial fibrillation, that is, three times more cases than experts had ...

Acesion Pharma ApS has announced promising data from preclinical studies with AP-31969, its second-generation oral SK channel inhibitor developed for chronic oral maintenance treatment to prevent ...

EAST LANSING, Mich. (WILX) - Michigan State University researchers have developed miniature hearts from human stem cells that ...

A new study by researchers at the University of Arizona College of Medicine – Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Atrial fibrillation (AFib) can lead to strokes and heart failure, ...

DISCLAIMER: I am not a medical professional. If you believe you have AFib or any other heart/medical condition that needs attention, please consult with your personal medical provider. You may be in ...